Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study

被引：0

作者：

Kiyo Tanaka

Norikazu Masuda

Naoki Hayashi

Yasuaki Sagara

Fumikata Hara

Takayuki Kadoya

Akira Matsui

Chieko Miyazaki

Tadahiko Shien

Eriko Tokunaga

Takako Hayashi

Naoki Niikura

Shigeto Maeda

Yoshihumi Komoike

Hiroko Bando

Chizuko Kanbayashi

Hiroji Iwata

机构：

[1] Toranomon Hospital,Department of Breast and Endocrine Surgery

[2] National Hospital Organization Osaka National Hospital,Department of Surgery, Breast Oncology

[3] St. Luke’s International Hospital,Department of Breast Surgery

[4] Sagara Hospital,Department of Breast Surgical Oncology

[5] Shikoku Cancer Center,Department of Breast Surgery

[6] Hiroshima University Hospital,Department of Breast Surgery

[7] National Hospital Organization,Department of Breast Surgery

[8] Tokyo Medical Center,Department of Breast Surgery

[9] Jichi Medical University Hospital,Department of Breast and Endocrine Surgery

[10] Okayama University Hospital,Department of Breast Oncology

[11] National Hospital Organization Kyusyu Cancer Center,Department of Breast Surgery

[12] National Hospital Organization,Department of Breast Surgery

[13] Nagoya Medical Center,Department of Surgery

[14] Tokai University Hospital,Department of Breast Surgery

[15] National Hospital Organization Nagasaki Medical Center,Department of Breast and Endocrine Surgery, Faculty of Medicine

[16] Kindai University Hospital,Department of Breast Oncology

[17] University of Tsukuba,Department of Breast Oncology

[18] Niigata Cancer Center Hospital,undefined

[19] Aichi Cancer Center Hospital,undefined

来源：

Breast Cancer | 2021年 / 28卷

关键词：

Breast cancer; Ductal carcinoma in situ; Dynamic magnetic resonance imaging; Predictive factors; Upstaging;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：896 / 903

页数：7

共 133 条

[1]

Jemal A(2007)Cancer statistics 2007 CA Cancer J Clin 57 43-48

[2]

Komoike Y(2015)Japan Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer Breast Cancer 22 37-745

[3]

Inokuchi M(2015)Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study JAMA Surg 150 739-63

[4]

Itoh T(2019)The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS) BMJ Open 9 e026797-1510

[5]

Kitamura K(2017)Surgery versus monitoring and endocrine therapy for low-risk DCIS: the COMET trial Bull Am Coll Surg 102 62-2303

[6]

Kutomi G(2015)Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ—the LORD study Eur J Cancer 51 1497-14

[7]

Sakai T(2014)Addressing overtreatment of screen detected DCIS; the LORIS trial Eur J Cancer 51 2296-314

[8]

Sagara Y(2007)Sentinel lymph node biopsy in staging small (up to 15mm) breast carcinomas. Results from a European multi-institutional study Pathol Oncol Res 13 5-645

[9]

Mallory MA(2006)Is there a role of sentinel lymph node biopsy inductal carcinoma in situ? Analysis of 587 cases Breast Cancer Res Treat 98 311-526

[10]

Wong S(2007)Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy Ann Surg Oncol 14 638-128

← 1 2 3 4 5 6 7 8 9 10 →